1. Pathophysiology and Treatment of Hepatitis C

   • H. C. Thomas
   • J. Booth
   • J. Brown

   Section 1: Keynote Presentations 13 October 2012 Pages: 1 - 8

2. The Inflammatory Cytokines

   • Michel P. Glauser

   Section 1: Keynote Presentations 13 October 2012 Pages: 9 - 17

3. Interleukin-12: Potential Clinical Applications in the Treatment and Prevention of Infectious Diseases

   • Maurice K. Gately
   • Michael J. Mulqueen

   Section 1: Keynote Presentations 13 October 2012 Pages: 18 - 26

4. Fluoroquinolones in Urinary Tract Infections

   • Kurt G. Naher

   Section 2: The Appropriate Use of Quinolones 13 October 2012 Pages: 27 - 33

5. The Appropriate Use of Quinolones

   • Alan Percival

   Section 2: The Appropriate Use of Quinolones 13 October 2012 Pages: 34 - 36

6. Discussion: Section 2

   Section 2: The Appropriate Use of Quinolones 13 October 2012 Pages: 37 - 41

7. Epidemiology, Control and Treatment of Multiresistant Pneumococci

   • Keith P. Klugman

   Section 3: Epidemiology, Control and Treatment of Multiresistant Organisms: Pneumococci, Enterococci and MRSA 13 October 2012 Pages: 42 - 46

8. Epidemiology and Control of Multiresistant Enterococci

   • Roland Leclercq

   Section 3: Epidemiology, Control and Treatment of Multiresistant Organisms: Pneumococci, Enterococci and MRSA 13 October 2012 Pages: 47 - 49

9. Epidemiology, Control and Treatment of Methicillin-Resistant Staphylococcus aureus

   • Georg Peters
   • Karsten Becker

   Section 3: Epidemiology, Control and Treatment of Multiresistant Organisms: Pneumococci, Enterococci and MRSA 13 October 2012 Pages: 50 - 54

10. Chronic Obstructive Pulmonary Disease

    • Stanley B. Fiel

    Section 4: Keynote Presentations 13 October 2012 Pages: 55 - 61

11. New Concepts in the Pathophysiology and Management of Middle Ear Disease in Childhood

    • Stephen I. Pelton

    Section 4: Keynote Presentations 13 October 2012 Pages: 62 - 67

12. The Challenge of Changing Healthcare Systems

    • Felix Weber

    Section 4: Keynote Presentations 13 October 2012 Pages: 68 - 77

13. Antibiotic Usage: Policy, Clinical and Pharmacoeconomic Outcomes

    • C. Carbon

    Section 5: Antibiotic Usage: Policy, Clinical and Pharmacoeconomic Outcomes 13 October 2012 Pages: 78 - 79

14. Antibiotic Usage: Pharmacoeconomic Impact in a Changing Healthcare System

    • Gary Milkovich

    Section 5: Antibiotic Usage: Policy, Clinical and Pharmacoeconomic Outcomes 13 October 2012 Pages: 80 - 82

15. Antibiotic Policies

    • Peter Davey

    Section 5: Antibiotic Usage: Policy, Clinical and Pharmacoeconomic Outcomes 13 October 2012 Pages: 83 - 87

16. Use of Antimicrobials in Swiss Hospitals

    • Daniel P. Lew
    • Jorge Garbino
    • Philippe Sudre the Swiss Committee of Anti-Infective Agents

    Section 5: Antibiotic Usage: Policy, Clinical and Pharmacoeconomic Outcomes 13 October 2012 Pages: 88 - 91

17. Discussion: Section 5

    Section 5: Antibiotic Usage: Policy, Clinical and Pharmacoeconomic Outcomes 13 October 2012 Pages: 92 - 94

18. Epidemiology, Control and Treatment of Multiresistant Gram-Negative Rods

    • Bernd Wiedemann

    Section 6: Epidemiology, Control and Treatment of Multiresistant Organisms: Gram-Negative Rods and Tuberculosis 13 October 2012 Pages: 95 - 102

19. Epidemiology, Control and Treatment of Multidrug-Resistant Tuberculosis

    • Pierre Chaulet
    • Mario Raviglione
    • Flavia Bustreo

    Section 6: Epidemiology, Control and Treatment of Multiresistant Organisms: Gram-Negative Rods and Tuberculosis 13 October 2012 Pages: 103 - 108